Olive Oil for Women's Health: Menopause & Period Research (2026)
- Nicolas Netien
- Jul 2
- 10 min read
Last Updated: July 2026
By Nicolas Netien, Chief Scientist at Oleaphen
Quick Answer
Extra virgin olive oil is studied in women's health for its polyphenols, above all oleocanthal and hydroxytyrosol, which act on the pathways behind inflammation, oxidation and metabolic regulation. These are not hormonal effects. Olive oil does not raise estrogen and does not act as a phytoestrogen, which is one of the most common questions and one of the clearest answers in the literature.
Where the effect is measured most solidly is cardiovascular and metabolic. The anti-inflammatory mechanism behind oleocanthal is well characterised and reaches directly into the biology of menstrual pain, and the compound has now been tested in a randomised human metabolic trial. One variable decides how much of any of this a person actually receives from a bottle: polyphenol concentration, which ranges across more than two orders of magnitude between oils.
In short
Oleocanthal and hydroxytyrosol act on inflammatory and metabolic pathways, not on hormones.
Olive oil does not raise estrogen and is not a phytoestrogen.
Oleocanthal inhibits COX-1 and COX-2 like ibuprofen (Beauchamp, Nature, 2005), and also suppresses NF-kB and MAPK signalling and lowers inflammatory cytokines.
The COX pathway is the same one that produces the prostaglandins behind menstrual cramps.
The cardiovascular evidence in humans is strong and dose-dependent on polyphenol content (EUROLIVE).
The 2026 rename of PCOS to PMOS centres the metabolic reality that olive oil research addresses.
Concentration is everything: a supermarket oil and an ultra-high-phenolic oil are not the same intervention
What the research on olive oil for women's health shows
Most clinical research on olive oil uses 20 to 30 ml per day within a normal diet. Two things decide how to read it.
First, olive oil and olive extracts are different tools. Some of the studies cited for menopause and bone used concentrated polyphenol extracts, which deliver far more of specific compounds than a spoon of ordinary oil. That does not make them irrelevant. It makes concentration the entire question, which is the theme running through everything below.
Second, polyphenol content varies by more than an order of magnitude:
negligible in refined or light olive oil
around 50 to 150 mg/kg in supermarket extra virgin oil
200 to 500 mg/kg in a good early-harvest extra virgin oil
500 to 1,000 mg/kg in high-phenolic oils
above 1,000 mg/kg in ultra-high-phenolic oils
For reference, our 2025/26 harvest tested at 2,236 mg/kg total polyphenols, with an oleocanthal fraction of 1,248 mg/kg, measured by LC-MS/MS at the IOC-accredited Universidad de Córdoba. Because the bioactive compounds rather than the fat drive the effects in these studies, 20 ml of a 50 mg/kg oil and 20 ml of a 2,000 mg/kg oil are not the same intervention, even though the label on both says extra virgin olive oil. The method used to measure this matters too, which is why olive oil testing methods are worth understanding before trusting any number on a bottle.
The mechanism: oleocanthal and the inflammatory pathways
The anchor discovery came in 2005, when Beauchamp and colleagues at the Monell Chemical Senses Center reported in Nature that oleocanthal, a polyphenol formed in fresh extra virgin olive oil, inhibits COX-1 and COX-2, the same enzymes ibuprofen acts on, at comparable potency on an equimolar basis.
COX enzymes generate prostaglandins, the lipid signals that drive inflammation and pain. In women's health this is direct: PGF2alpha and PGE2 produce the uterine contractions behind menstrual cramping.
The mechanism does not stop at COX. Later work, summarised in our full piece on oleocanthal and its anti-inflammatory pathway, documents that oleocanthal suppresses NF-kB and MAPK signalling in human cells, reduces the phosphorylation of the ERK and p38 kinases, and lowers a wide panel of inflammatory mediators including IL-6, IL-8, TNF-alpha and MIP-1alpha (Scotece et al., Cellular Physiology and Biochemistry, 2018). It also modulates platelet aggregation through the same thromboxane pathway that low-dose aspirin uses, shown in a randomised human trial in healthy men (Agrawal et al., Journal of Functional Foods, 2017).
This is a broad, well-mapped anti-inflammatory profile, and it is the reason researchers looked for effects in the parts of women's health where inflammation and metabolism are central.
Olive oil and period pain: mechanism and evidence
Menstrual cramps are largely a prostaglandin story, so a compound that inhibits COX and the wider inflammatory cascade is a rational thing to study here.
The mechanistic evidence is direct. In a 2020 study in Nutrients, Chiang and colleagues showed in uterine tissue and an animal pain model that oleocanthal binds the same COX-2 site as ibuprofen, reduces PGF2alpha-induced uterine contraction, and lowers oxidative stress in the tissue. This maps the mechanism onto the exact physiology of the cramp.
The human signal points the same way. A 2015 crossover trial in 60 women with primary dysmenorrhea had participants take 25 ml of extra virgin olive oil daily for two months, beginning two weeks before menstruation. Reported pain on a 10-point scale fell from 6.7 at baseline to 1.1 during the olive oil phase. The trial was small and single-blind, and its design suited olive oil's mechanism, since oleocanthal works through sustained anti-inflammatory exposure rather than acute rescue dosing. Read alongside the mechanism, it is a coherent early human result rather than an outlier.
The honest framing, and the one that matches the biology, is the one we use for oleocanthal generally: the case is chronic low-grade anti-inflammatory exposure across regular consumption, not a painkiller you reach for during a cramp.
Olive oil and menopause: where the evidence is strongest
Menopause brings declining estrogen, shifts in fat distribution and lipid metabolism, and a marked rise in cardiovascular risk.
Olive oil does not change hormone production. It acts on the systems that hormonal decline leaves exposed, and this is where its human evidence is at its best.
The cardiovascular case is solid. The EUROLIVE study (Covas et al., Annals of Internal Medicine, 2006) had participants take 25 ml per day of olive oils that differed only in polyphenol content. As polyphenols rose, HDL function improved and LDL oxidation fell, in a clear dose-dependent relationship. The effect tracked the polyphenols, not the fat. This dose-response is the scientific backbone of the EU-authorised health claim, and it matters most exactly when cardiovascular risk climbs after menopause.
For menopausal symptoms specifically, the standout trial used a concentrated olive leaf extract rather than oil: a 2024 randomised, double-blind, placebo-controlled study in 60 postmenopausal women reported improved menopause-specific quality-of-life scores within six weeks.
Bone research points the same direction. A 12-month randomised trial in 64 postmenopausal women with osteopenia (NCT00789425) found that a daily olive polyphenol extract produced a significant rise in serum osteocalcin, a marker of bone formation, and kept bone mineral density stable while it fell in the placebo group.
Both used concentrated extracts, and that is the point worth sitting with. The dose that moved these outcomes is far above what a supermarket oil at 50 mg/kg could ever deliver. It is not far above what a serving of an ultra-high-phenolic oil delivers.
A 20 g serving at the EU claim threshold provides 5 mg of hydroxytyrosol and derivatives; the same serving of our 2025/26 harvest provides close to 45 mg, roughly nine times that threshold.
Concentration is what moves an oil from the supermarket category toward the doses these studies actually used.
Olive oil and PMOS: metabolic, not hormonal
In May 2026, polycystic ovary syndrome was formally renamed polyendocrine metabolic ovarian syndrome, or PMOS, in a global consensus published in The Lancet and endorsed by the Endocrine Society and more than fifty organisations.
The rename happened because the condition is primarily metabolic and endocrine, not a disease of ovarian cysts. That is worth noting here, because the metabolic axis, insulin resistance and low-grade inflammation, is exactly where olive oil research operates.
A 2021 randomised controlled trial in Lipids in Health and Disease gave 72 women with PMOS 25 g per day of canola, olive or sunflower oil for ten weeks. In the olive oil group, insulin resistance measured by HOMA-IR fell significantly, and fatty liver grade improved. Canola oil produced the broadest lipid improvements in that particular trial, which is worth stating plainly, but the olive oil result on insulin resistance and liver fat is real and consistent with the wider metabolic literature.
That wider literature is where oleocanthal's newest human data sits. The APRIL trial (Clinical Nutrition, 2023) fed people with obesity and prediabetes an oleocanthal- and oleacein-enriched olive oil and measured improvements in antioxidant status and reductions in inflammatory markers, targeting the compounds rather than total polyphenols. For the mechanism connecting olive oil polyphenols to insulin and metabolic signalling, our piece on olive oil polyphenols and GLP-1 metabolic health goes deeper.
How much, and why volume is the wrong unit
Most studies report intake in millilitres, usually 20 to 30 ml per day over weeks to months. On its own that number is close to meaningless, because the studies rarely state the polyphenol content of the oil they used, and much of it was ordinary oil low in phenolics.
The effect a study measured came from whatever polyphenol dose those millilitres carried, which was often modest.
This is the practical reason concentration matters more than volume. A teaspoon of a 2,000 mg/kg oil carries the polyphenol load of a large glass of a 100 mg/kg one. It is also why format and freshness matter, since oleocanthal degrades on contact with air and light. Our own reasons a daily shot and monodose approach come straight from that chemistry.
Safety
Olive oil is one of the most widely eaten fats in the world and holds GRAS status with the US FDA. At the intakes used in research it is well tolerated. A 20 to 25 ml serving contributes roughly 180 to 220 kcal, and some people notice mild digestive adjustment when they first increase intake, which usually settles. If you take regular medication or have a medical condition, speak with your doctor before a large dietary change. We cover this fully in our guide to the side effects of high-polyphenol olive oil.
What actually makes an oil useful here
If the compounds do the work, then concentration and freshness separate one oil from another, and a total-polyphenol number alone is not enough. Oleocanthal in particular is formed during processing and varies widely even among oils with high total figures, so the useful certificate is one that lists oleocanthal as its own line item, measured by LC-MS/MS, from a recent harvest.
When comparing oils, look for a dated harvest, protective packaging that excludes oxygen, traceability to a mill, and a compound-level lab analysis rather than an adjective. Our buying guide to high-polyphenol olive oil compares the brands that publish full data.
Frequently asked questions
Does olive oil increase estrogen?
No. There is no good evidence that olive oil raises estrogen or mimics it. Unlike the phytoestrogens in some plant foods, olive oil polyphenols do not bind estrogen receptors. Researchers study them for antioxidant and anti-inflammatory activity, not for hormonal effects.
What did the olive oil and period-pain study find?
A 2015 crossover trial in 60 women reported that daily extra virgin olive oil, taken across the cycle, was associated with lower menstrual pain scores than baseline. It was a small, single-blind study, and it fits the mechanism, since oleocanthal works through sustained anti-inflammatory exposure rather than acute pain relief. It is an early human signal, not a reason to stop any medication.
Are the menopause and bone findings about olive oil or extracts?
The strongest menopause-symptom and bone studies used concentrated olive polyphenol or leaf extracts, which deliver far higher doses than a supermarket oil. An ultra-high-phenolic oil sits much closer to those doses, which is the reason concentration is the whole question.
Is olive oil relevant to PMOS, formerly PCOS?
PMOS is a metabolic and endocrine condition. In a 2021 trial, olive oil was associated with lower insulin resistance and improved fatty liver grade in women with the condition. Its relevance is metabolic and anti-inflammatory, not hormonal.
Does cooking destroy the polyphenols?
Heat reduces them, more so at high temperatures. For the compounds these studies focus on, use the oil raw, as a finishing oil or a daily shot.
Key takeaways
Olive oil's role in women's health is anti-inflammatory and metabolic, not hormonal, and it does not raise estrogen.
Oleocanthal inhibits COX like ibuprofen and also suppresses NF-kB, MAPK and inflammatory cytokines, reaching directly into the biology of menstrual pain.
The cardiovascular evidence in humans is strong and rises with polyphenol content.
The 2026 rename to PMOS underlines the metabolic axis where olive oil research is active.
Concentration decides the dose. A supermarket oil and an ultra-high-phenolic oil are different interventions.
Conclusion
Olive oil is a food with one of the most interesting molecules in nutrition science inside it. Oleocanthal's anti-inflammatory pathway is well mapped, its cardiovascular and metabolic effects in humans are real and dose-dependent on polyphenol content, and the mechanism connects cleanly to the parts of women's health where inflammation and metabolism dominate. What decides how much of this reaches a person is not whether the bottle says extra virgin, but how much polyphenol it actually contains and how well that content survives to the point of use.
Try the highest oleocanthal olive oil independently verified
Our 2025 harvest sold out across 31 countries. The October 2026 harvest is opening for pre-order. Join the 2026 harvest waitlist.
About the author
Nicolas Netien is Chief Scientist at Oleaphen. He has spent fifteen years on the science of high phenolic olive oil, from cultivation through to extraction, and holds the world record for the highest polyphenol concentration ever measured in olive oil, 4,943 mg/kg, set in 2018. He is a Knight of the Order of Agricultural Merit of the French Republic.
He writes about olive oil chemistry, not clinical medicine. The studies cited here are the work of the named researchers and institutions, and nothing on this page is medical advice.
References
Beauchamp GK, Keast RSJ, Morel D, et al. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature. 2005;437(7055):45-46.
Scotece M, Gómez R, Conde J, et al. Oleocanthal inhibits catabolic and inflammatory mediators in LPS-activated human primary osteoarthritis chondrocytes through MAPKs/NF-kB pathways. Cellular Physiology and Biochemistry. 2018;49(6):2414-2426.
Agrawal K, Melliou E, Li X, et al. Oleocanthal-rich extra virgin olive oil demonstrates acute anti-platelet effects in healthy men in a randomized trial. Journal of Functional Foods. 2017;36:84-93.
Chiang YF, Chen HY, Chang YJ, et al. The inhibitory effect of extra virgin olive oil and its active compound oleocanthal on prostaglandin-induced uterine hypercontraction and pain, ex vivo and in vivo study. Nutrients. 2020;12(10):3012.
Rezaeyan M, Khedri P, Abdali N, Direkvand-Moghadam A. The impact of extra virgin olive oil on primary dysmenorrhea in comparison to ibuprofen. Der Pharmacia Lettre. 2015;7(11):212-216.
Yahay M, Heidari Z, Allameh Z, Amani R. The effects of canola and olive oils consumption compared to sunflower oil, on lipid profile and hepatic steatosis in women with polycystic ovarian syndrome: a randomized controlled trial. Lipids in Health and Disease. 2021;20(1):7. doi:10.1186/s12944-021-01433-9.
Filip R, Possemiers S, Heyerick A, Pinheiro I, Raszewski G, Davicco MJ, Coxam V. Twelve-month consumption of a polyphenol extract from olive (Olea europaea) in a double blind, randomized trial increases serum total osteocalcin levels and improves serum lipid profiles in postmenopausal women with osteopenia. The Journal of Nutrition, Health and Aging. 2015;19(1):77-86. doi:10.1007/s12603-014-0480-x.
Imperatrice M, Lasfar A, van Kalkeren CAJ, Troost FJ. Olive leaf extract supplementation improves postmenopausal symptoms: a randomized, double-blind, placebo-controlled parallel study on postmenopausal women. Nutrients. 2024;16(22):3879. doi:10.3390/nu16223879.
Covas MI, Nyyssönen K, Poulsen HE, et al. The effect of polyphenol content in olive oil on heart disease risk factors: a randomized trial (EUROLIVE). Annals of Internal Medicine. 2006;145(5):333-341.
Ruiz-García I, Ortíz-Flores R, Badía R, et al. Rich oleocanthal and oleacein extra virgin olive oil and inflammatory and antioxidant status in people with obesity and prediabetes. The APRIL study. Clinical Nutrition. 2023;42(8):1389-1398.
Teede HJ, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. 2026.